Suppr超能文献

经颈静脉肝内门体分流术(TIPS)植入术后3个月仍有少量残留腹水提示肝硬化患者临床预后较差。

Minimal residual ascites 3 months after TIPS implantation implicates worse clinical outcomes in patients with cirrhosis.

作者信息

Mauz Jim Benjamin, Hartl Lukas, Kornfehl Andrea, Schütte Sarah Lisa, Hemetsberger Paul, Müllner-Bucsics Theresa, Jachs Mathias, Tiede Anja, Rieland Hannah, Schwarz Michael, Dominik Nina, Kramer Georg, Meyer Bernhard, Reider Lukas, Trauner Michael, Wedemeyer Heiner, Mandorfer Mattias, Maasoumy Benjamin, Reiberger Thomas, Tergast Tammo Lambert

机构信息

Department of Gastroenterology, Hepatology, Infectious Diseases and Endocrinology, Hannover Medical School, Hannover, Germany.

Division of Gastroenterology and Hepatology, Department of Medicine III, Medical University of Vienna, Vienna, Austria.

出版信息

JHEP Rep. 2025 Jan 23;7(7):101335. doi: 10.1016/j.jhepr.2025.101335. eCollection 2025 Jul.

Abstract

BACKGROUND & AIMS: Transjugular intrahepatic portosystemic shunt (TIPS) implantation is indicated for recurrent/refractory ascites in patients with cirrhosis. The prognostic impact of residual minimal ascites after TIPS implantation has not yet been investigated.

METHODS

We included patients with cirrhosis undergoing covered TIPS implantation for refractory ascites in Vienna (2000-2022) and Hannover (2009-2021) with available abdominal ultrasound 3 months after TIPS insertion (3M). The patients were followed up for further decompensation and transplant-free mortality. Two distinct competing risk regression models (Adjusted model I and Adjusted model II) were performed to determine the prognostic impact of no minimal ascites at 3M.

RESULTS

Overall, 292 patients with male predominance (71.7%) and mostly alcohol-related liver disease (71.7%) were included. At 3M, n = 105 (36.0%) patients showed no ascites on abdominal ultrasound, whereas n = 82 (28.1%) exhibited minimal and n = 105 (36.0%) moderate/severe ascites. The portal pressure gradient after TIPS implantation was similar in the three groups (median 7 mmHg; = 0.311). Patients with no or minimal ascites had comparable Model for End-Stage Liver Disease and Freiburg Index of Post-TIPS Survival scores at baseline and 3M. Competing risk regression models showed that minimal ascites ( no ascites) was an independent predictor of further decompensation (Adjusted model I: adjusted subdistribution hazard ratio [aSHR], 1.69; 95% CI, 1.03-2.77; = 0.038; Adjusted model II: aSHR, 1.76; 95% CI, 1.07-2.88; = 0.026) and transplant-free mortality (Adjusted model I: aSHR, 1.76; 95% CI, 1.08-2.88; = 0.024; Adjusted model II: aSHR, 1.73; 95% CI, 1.05-2.82; = 0.030).

CONCLUSIONS

Patients with residual minimal ascites at 3M remain at higher risk for further decompensation and transplant-free mortality compared with those with no residual ascites.

IMPACT AND IMPLICATIONS

This study evaluated the prognostic relevance of residual ascites grades in patients with advanced chronic liver disease after TIPS placement. Severe ascites was linked to the worst outcomes, underscoring the need for urgent liver transplantation evaluation. However, even minimal residual ascites significantly increased the risk of further decompensation and transplant-free mortality. These findings suggest that patients with minimal residual ascites will benefit from enhanced post-TIPS clinical monitoring. Further research is warranted to uncover the underlying mechanisms and investigate the potential of targeted interventions to improve outcomes in this vulnerable group.

摘要

背景与目的

经颈静脉肝内门体分流术(TIPS)植入适用于肝硬化患者反复出现的/难治性腹水。TIPS植入后残余少量腹水的预后影响尚未得到研究。

方法

我们纳入了在维也纳(2000 - 2022年)和汉诺威(2009 - 2021年)因难治性腹水接受覆膜TIPS植入的肝硬化患者,这些患者在TIPS植入后3个月(3M)有可用的腹部超声检查结果。对患者进行随访,观察进一步失代偿情况和无移植生存率。采用两种不同的竞争风险回归模型(调整模型I和调整模型II)来确定3M时无少量腹水的预后影响。

结果

总体而言,纳入了292例患者,以男性为主(71.7%),主要为酒精性肝病(71.7%)。在3M时,n = 105例(36.0%)患者腹部超声检查显示无腹水,而n = 82例(28.1%)有少量腹水,n = 105例(36.0%)有中度/重度腹水。三组患者TIPS植入后的门静脉压力梯度相似(中位数7 mmHg;P = 0.311)。无腹水或少量腹水的患者在基线和3M时的终末期肝病模型和TIPS术后生存弗赖堡指数评分相当。竞争风险回归模型显示,少量腹水(对比无腹水)是进一步失代偿的独立预测因素(调整模型I:调整后亚分布风险比[aSHR],1.69;95%置信区间,1.03 - 2.77;P = 0.038;调整模型II:aSHR,1.76;95%置信区间,1.07 - 2.88;P = 0.026)和无移植死亡率的独立预测因素(调整模型I:aSHR,1.76;95%置信区间,1.08 - 2.88;P = 0.024;调整模型II:aSHR,1.73;95%置信区间,1.05 - 2.82;P = 0.030)。

结论

与无残余腹水的患者相比,3M时残余少量腹水的患者进一步失代偿和无移植死亡率的风险仍然更高。

影响与启示

本研究评估了TIPS置入术后晚期慢性肝病患者残余腹水等级的预后相关性。严重腹水与最差的预后相关,强调了紧急肝移植评估的必要性。然而,即使是少量残余腹水也显著增加了进一步失代偿和无移植死亡率的风险。这些发现表明,残余少量腹水的患者将从TIPS术后加强临床监测中获益。有必要进一步研究以揭示潜在机制,并探讨针对性干预措施改善这一脆弱群体预后的潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a787/12167471/fa0fe49b9ab0/ga1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验